Back

Prognostic significance of clonal haematopoiesis of indeterminate potential-mutations with inflammation biomarkers in patients with STEMI

30 August 2025 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Biomarkers in acute coronary syndromes (3) Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Xiaoxiao Zhao

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular D, Beijing (China)

6 More presentations in this session

Presentation thumbnail
Association of free fatty acids with long-term adverse outcomes in patients with premature myocardial infarction: a prospective cohort study
Professor J. Gao (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
Plasma proteomics based sub-phenotypes in coronary artery disease are related to plaque characteristics and clinical outcome
Doctor J. Veiga-Fernandes Mira (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Comparison of generation 6 and generation 5 high-sensitivity cardiac troponin T assays in the early diagnosis of myocardial infarction
Doctor L. Koechlin (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Hemoglobin and long-term risk of death in patients with acute myocardial infarction
Doctor M. Todorovic Markovic (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
What is the optimal single sample rule out threshold using a point of care high-sensitivity troponin i assay?
Doctor J. Hatherley (Liverpool, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Biomarkers in acute coronary syndromes (3)

The Event

Event poster

ESC Congress 2025

30 August 2025 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Clonal haematopoiesis
thumbnail
Congress Presentation
Clonal hematopoiesis of indeterminate potential predicts new-onset myocarditis and pericarditis
thumbnail
Congress Presentation
Combined effects of clonal hematopoiesis of intermediate potential and P2Y12 inhibitors on outcomes of patients with ST-segment elevation myocardial infarction: A prospective study

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources